Massachusetts Institute of Technology professor Phillip Sharp co-founded Alnylam with several others in 2002. It wasn't Sharp ...

The CDC’s top vaccine advisory panel has voted to end the long-standing recommendation that all newborns receive a hepatitis ...

“By accelerating the production and sharing of trustworthy data, as we are doing at MassCPR, we can empower the public with ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

A research team drawn from Sweden, Germany, Italy and France has created the most complete ‘molecular film’ to date of a self ...

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack ...

Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...

While a method to create iPS cells using skin cells and synthetic RNA has already been developed, it had been thought to be ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic areas, and ...

This comes as new CHB functional cures are expected to arrive. The chronic hepatitis B (CHB) therapeutics market size in ...

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have ...

An FDA‑approved medication called spironolactone, often prescribed as a diuretic, or water pill, for heart and blood pressure ...